BUZZ - Cloud service provider Akamai shares rise after issuing $2.2 billion in convertible bonds
路透社2026/11/10 15:41November 10 - ** The share price of cloud service provider Akamai Technologies (AKAM.O) rose 2.1% to $81.98 in early trading on Tuesday, after the company successfully completed a round of financing
** On Monday evening, AKAM announced (link) the pricing of $1.1 billion of convertible bonds due November 15, 2028, with a coupon rate of 1%, and another $1.1 billion of convertible bonds due November 15, 2031, also with a coupon rate of 1%
** The conversion price for the 2028 bonds is set at $112.41, representing a 40% premium to the previous trading day's closing price; the conversion price for the 2031 bonds is $102.37, a 27.5% premium
** On Monday, AKAM shares fell 3.4% after the company (link) announced that proceeds from the issuance would be used at maturity to repay a portion of the $1.15 billion outstanding 0.375% convertible bonds due 2027, as well as to fund capital expenditures for its cloud infrastructure services business
** The company also plans to use about $250.3 million of the net proceeds to pay for the cost of convertible note hedge transactions, to help mitigate potential dilution effects
** Due to recent market performance, the stock is down about 6% year to date. In comparison, the S&P 500 Technology Index .SPLRCT has gained about 13% so far this year, while the Nasdaq Index .IXIC has risen 8%
** According to the latest data from London Stock Exchange Group (LSEG), the average rating from 24 analysts is "Buy"; the median target price is $122.50
(To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Because automated translation may contain errors or fail to include necessary context, Reuters does not guarantee the accuracy of the automated translation and provides it solely for readers’ convenience. Reuters accepts no responsibility for any damages or losses arising from the use of the automated translation feature.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like


The three major U.S. stock indexes have risen, and the Nasdaq 100 index has turned positive.

Pfizer CEO Albert Bourla Joins Jefferies Healthcare Conference Discussion